Premier Alternatives

Maxwell Biosciences

Austin, TX · Founded 2016 · Privately Held (backing)

Operator of a drug platform company intended to create biomimetic therapeutics and synthetic compounds that mimic and improve upon biomolecules. Maxwell Biosciences is based in Austin, TX and was founded in 2016. It was valued at $50.9 million at its seed round in Oct 2023, the last priced event on record. It has raised $35.5 million across 1 recorded round; the latest was a $10.9 million early-stage round in Oct 2021.

PMV mark · valuation
$50.9M
Oct 2026
Priced at
its seed round
Oct 2023
Total raised
$35.5M
Last round
Early Stage VC
Oct 2021

Maxwell Biosciences key facts

as of Oct 2026
  • Operator of a drug platform company intended to create biomimetic therapeutics and synthetic compounds that mimic and improve upon biomolecules.
  • Maxwell Biosciences is valued at approximately $50.9M as of Oct 2026, set at its seed round, Oct 2023; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $35.5M across 1 recorded rounds; the latest was Early Stage VC ($10.9M) in Oct 2021.
  • Notable investors include U.S. Department of Energy, Capital Factory, National Institutes of Health, Keiretsu Forum, Endless Frontier Labs — 30 tracked in total.
  • Maxwell Biosciences has filed 2 Form Ds with the SEC since 2022, most recently Jul 2023 ( sold).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$50.9M

Valued at $50.9M at its seed round, Oct 2023. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Maxwell Biosciences with a free account
  • ·The complete investor list: 30 names
  • ·Watch Maxwell Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Maxwell Biosciences funding rounds

1 rounds
Oct 2021Early Stage VC$10.9MSEC filing▮
Full funding history →

Maxwell Biosciences valuation

Maxwell Biosciences was valued at $50.9 million at its seed round in Oct 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Maxwell Biosciences raised?

Maxwell Biosciences has raised $35.5 million in total; 1 of its rounds is on record. The largest on record was a $10.9 million early-stage round in Oct 2021.

Maxwell Biosciences has filed 2 Form Ds with the SEC since 2022, most recently in Jul 2023 (null sold).

Maxwell Biosciences investors

30 investors are on record for Maxwell Biosciences, including U.S. Department of Energy, Capital Factory, National Institutes of Health and Keiretsu Forum. The early-stage round in Oct 2021 drew 96 investors.

About Maxwell Biosciences

Operator of a drug platform company intended to create biomimetic therapeutics and synthetic compounds that mimic and improve upon biomolecules. The company's platform effectively destroys viruses, bacteria, fungi, and some cancers, while avoiding healthy cells in human tissues and animal studies, where compounds imitate key immune system components, enabling healthcare professionals to treat formerly untreatable conditions.

Sector
Healthcare
HQ
Austin, TX, United States
Founded
2016
Employees
23
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.